In silico analyses confirmed the transcriptional upregulation of IL6 and RBP4 in CRC and revealed distinct molecular pathways—immune/inflammatory signaling for IL-6 and developmental signaling for RBP4—highlighting their possible contributions to tumor biology. The gene discussed is IL6; the disease is neoplasm.